House Bill 2071
117th Congress(2021-2022)
Medicare Prescription Drug Price Negotiation Act of 2021
Introduced
Introduced in House on Mar 18, 2021
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
2071
Congress
117
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
No House votes have been held for this bill.
Summary
Medicare Prescription Drug Price Negotiation Act of 2021
This bill requires the Centers for Medicare & Medicaid Services (CMS) to negotiate with pharmaceutical companies regarding prices for drugs covered under the Medicare prescription drug benefit. Current law prohibits the CMS from doing so.
March 18, 2021
03/19/2021
Referred to the Subcommittee on Health.
03/18/2021
Referred to the Subcommittee on Health.
03/18/2021
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
03/18/2021
Introduced in House
Public Record
Record Updated
Jan 11, 2023 1:48:07 PM